Mir-125A Augments the Inhibition of Breast Cancer Proliferation by Docetaxel

CAI Yang,TAO Li,TAN Yue,YANG Mei,YANG Xin-miao,HU Xi-chun

DOI: https://doi.org/10.3969/j.issn.1007-3969.2011.10.002

2011-01-01

Abstract:Background and purpose:MiR-125a is known to inhibit the proliferation of breast carcinoma cells by knockdown Her-2/3 gene expressions,hence,miR-125a may be a novel therapy target.This study was to investigate the effect of miR-125a in the inhibition of docetaxel in the breast cancer proliferation.Methods:MCF-7 and MDA-MB-231 breast cancer cell lines and MDA-MB-231 breast cancer nude mice model with transferring miR-125a combined with docetaxel.The inhibition effect in the breast cancer proliferation was observed in the cell line and the nude mice model.Results:miR-125a has synergistic inhibition effect with docetaxel in proliferation of MDA-MB-231 and MCF-7 breast cancer cell lines,and the similar result was acquired in MDA-MB-231 breast cancer nude mice model.From this study,we also confirmed that MDA-MB-231 and MCF-7 breast cancer cell lines can be inhibited by transferring miR-125a alone.Conclusion:miR-125a has synergistic action with docetaxel in inhibiting the growth of breast cancer cell line and nude mice model,and miR-125a could be a potential target in breast cancer treatment.